AMED vs ZD
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AMED is a Buy and ZD is a Buy.
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
AMED’s FA Score shows that 0 FA rating(s) are green whileZD’s FA Score has 0 green FA rating(s).
- AMED’s FA Score: 0 green, 5 red.
- ZD’s FA Score: 0 green, 5 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
AMED’s TA Score shows that 6 TA indicator(s) are bullish while ZD’s TA Score has 5 bullish TA indicator(s).
- AMED’s TA Score: 6 bullish, 4 bearish.
- ZD’s TA Score: 5 bullish, 3 bearish.
Price Growth
AMED (@Medical/Nursing Services) experienced а +1.28% price change this week, while ZD (@Advertising/Marketing Services) price change was -3.09% for the same time period.
The average weekly price growth across all stocks in the @Medical/Nursing Services industry was +1.73%. For the same industry, the average monthly price growth was +2.85%, and the average quarterly price growth was +5.88%.
The average weekly price growth across all stocks in the @Advertising/Marketing Services industry was +2.46%. For the same industry, the average monthly price growth was +6.06%, and the average quarterly price growth was -5.72%.
Reported Earning Dates
AMED is expected to report earnings on Jul 23, 2025.
ZD is expected to report earnings on Jul 31, 2025.
Industries' Descriptions
@Medical/Nursing Services (+1.73% weekly)The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.
@Advertising/Marketing Services (+2.46% weekly)Making a brand known to people, garnering more clients/consumers for its product and solidifying the brand’s position in an industry – all of these are essential to a company’s growth, and that’s where marketing/advertising come in as one of the key catalysts. Advertising industry is a global multibillion-dollar business of public relations and marketing companies, media services and advertising agencies – entities that help to connect manufacturers/producers with customers. Digital media has played a big role in the growth of global advertising, and agencies invest substantially to integrate advanced technologies into their business operations. According to some estimates, the U.S. advertising industry is expected to generate revenue of $52.6 billion by 2023, up from almost $40 billion in 2015 . Omnicom Group Inc., Trade Desk, Inc. and Interpublic Group of Companies, Inc. are some of the major U.S. companies in the industry.
| AMED | ZD | AMED / ZD | |
| Capitalization | 3.02B | 2.91B | 104% |
| EBITDA | 129M | 332M | 39% |
| Gain YTD | 4.450 | -45.694 | -10% |
| P/E Ratio | 1170.50 | 70.17 | 1,668% |
| Revenue | 2.24B | 1.36B | 164% |
| Total Cash | 126M | 765M | 16% |
| Total Debt | 487M | 1B | 49% |
AMED | ZD | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 26 | 54 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 76 Overvalued | 79 Overvalued | |
PROFIT vs RISK RATING 1..100 | 100 | 100 | |
SMR RATING 1..100 | 77 | 85 | |
PRICE GROWTH RATING 1..100 | 50 | 91 | |
P/E GROWTH RATING 1..100 | 47 | 96 | |
SEASONALITY SCORE 1..100 | 50 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
AMED's Valuation (76) in the Medical Or Nursing Services industry is in the same range as ZD (79) in the Internet Software Or Services industry. This means that AMED’s stock grew similarly to ZD’s over the last 12 months.
AMED's Profit vs Risk Rating (100) in the Medical Or Nursing Services industry is in the same range as ZD (100) in the Internet Software Or Services industry. This means that AMED’s stock grew similarly to ZD’s over the last 12 months.
AMED's SMR Rating (77) in the Medical Or Nursing Services industry is in the same range as ZD (85) in the Internet Software Or Services industry. This means that AMED’s stock grew similarly to ZD’s over the last 12 months.
AMED's Price Growth Rating (50) in the Medical Or Nursing Services industry is somewhat better than the same rating for ZD (91) in the Internet Software Or Services industry. This means that AMED’s stock grew somewhat faster than ZD’s over the last 12 months.
AMED's P/E Growth Rating (47) in the Medical Or Nursing Services industry is somewhat better than the same rating for ZD (96) in the Internet Software Or Services industry. This means that AMED’s stock grew somewhat faster than ZD’s over the last 12 months.
| AMED | ZD | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 42% | 2 days ago 67% |
| Stochastic ODDS (%) | 2 days ago 54% | 2 days ago 63% |
| Momentum ODDS (%) | 2 days ago 52% | 2 days ago 69% |
| MACD ODDS (%) | 2 days ago 51% | 2 days ago 60% |
| TrendWeek ODDS (%) | 2 days ago 49% | 2 days ago 70% |
| TrendMonth ODDS (%) | 2 days ago 43% | 2 days ago 70% |
| Advances ODDS (%) | 2 days ago 53% | 8 days ago 64% |
| Declines ODDS (%) | 24 days ago 60% | 2 days ago 71% |
| BollingerBands ODDS (%) | 2 days ago 49% | 2 days ago 49% |
| Aroon ODDS (%) | 2 days ago 48% | 2 days ago 67% |
AMED and
Correlation & Price change
A.I.dvisor tells us that AMED and ENSG have been poorly correlated (+25% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that AMED and ENSG's prices will move in lockstep.
| Ticker / NAME | Correlation To AMED | 1D Price Change % | ||
|---|---|---|---|---|
| AMED | 100% | +0.12% | ||
| ENSG - AMED | 25% Poorly correlated | +0.59% | ||
| TALK - AMED | 24% Poorly correlated | -2.85% | ||
| OPCH - AMED | 23% Poorly correlated | +5.25% | ||
| BKD - AMED | 22% Poorly correlated | +0.77% | ||
| EHAB - AMED | 21% Poorly correlated | +0.38% | ||
More | ||||
ZD and
Correlation & Price change
A.I.dvisor indicates that over the last year, ZD has been loosely correlated with DLX. These tickers have moved in lockstep 58% of the time. This A.I.-generated data suggests there is some statistical probability that if ZD jumps, then DLX could also see price increases.